Continuation of Nintedanib After Single Lung Transplantation in IPF Subjects
Conditions: Idiopathic Pulmonary Fibrosis; Lung Transplant; Complications Interventions: Drug: Nintedanib; Drug: Placebo Oral Tablet Sponsors: Temple University; Boehringer Ingelheim Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials